Companies LeonaBio, Inc.
LeonaBio (LONA): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me LeonaBio, Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO pay, last three years
- $1,423,814FY2025
CEO total pay was $1,423,814 in fiscal 2025; the brief holds no earlier figure for this CEO.
FY2025: salary $625,000 · bonus $171,875 · stock awards $83,720 · option awards $518,135
Frequently asked questions
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Mark Litton | $625,000 | $171,875 | $83,720 | $518,135 | $0 | $0 | $25,085 | $1,423,814 |
| President and Chief Executive Officer | ||||||||
| Javier Martin | 500,000 | 100,000 | 27,907 | 182,143 | 0 | 0 | 85 | 810,134 |
| Chief Medical Officer | ||||||||
| Mark Worthington | 450,000 | 90,000 | 21,541 | 140,601 | 0 | 0 | 29,335 | 731,477 |
| General Counsel, Chief Compliance Officer and Corporate Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Mark Litton | $1,423,814 | — | — | — |
| Javier Martin | 810,134 | — | — | — |
| Mark Worthington | 731,477 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
No outstanding equity awards are on file for this fiscal year.
Director compensation
No director compensation table is on file for fiscal year 2025.
Peer group, and who names LeonaBio as a peer
Companies that benchmark against LONA
No companies currently name LONA as a compensation peer in their most recent disclosure.
This is the complete answer, not a partial one — the list is never padded.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | LeonaBio, Inc. | 2025 | Mark Litton | $625,000 | $83,720 | $518,135 | $0 | $1,423,814 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Say-on-pay history and pay ratio
No say-on-pay vote is on file for this company.
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (4 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Mark Litton. DEF 14A, filed 2026-05-11. Section “2024 – 2025 Summary Compensation Table” · page 30. As printed: 1,423,814. View filing ↗
- Section 01, Javier Martin. DEF 14A, filed 2026-05-11. Section “2024 – 2025 Summary Compensation Table” · page 30. As printed: 810,134. View filing ↗
- Section 01, Mark Worthington. DEF 14A, filed 2026-05-11. Section “2024 – 2025 Summary Compensation Table” · page 30. As printed: 731,477. View filing ↗
- LeonaBio, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-05-11. CEO total compensation as printed in LeonaBio, Inc.'s own proxy. As printed: 1,423,814. View filing ↗